Decentralising DOT for drug-susceptible TB from the health facilities to the community level in Togo

F.M. Dogo,S. Ate,K. Agossou,S. Menon,A.A. Fiogbé,K. Akpadja,S.K. Adjoh,V. Veronese,C.S. Merle,K.G. Koura
DOI: https://doi.org/10.5588/ijtld.23.0427
2024-04-01
The International Journal of Tuberculosis and Lung Disease
Abstract:BACKGROUND In Togo, the COVID-19 pandemic paved the way for decentralising directly observed treatment (DOT) to the community level through the evaluation of two innovative community-based DOT approaches—a community health worker-based (CHW-DOT) and family-based (FB-DOT). METHODS We conducted an observational prospective study from April 2021 to January 2022. Sputum conversion at Month 2 and favourable treatment outcomes at Month 6 were assessed and compared between the two groups. Sociodemographic and clinical factors related to these outcomes were identified. RESULTS A total of 182 TB patients were enrolled. The CHW-DOT group had significantly increased odds of sputum conversion (aOR 2.95, 95% CI 1.09–7.98) and lower odds of unsuccessful treatment outcomes (aOR 0.37, 95% CI 0.13–1.1). Non-smokers had 4.85 higher odds of converting than smokers (aOR 4.85, 95% CI 1.76–13.42) and lower odds of an unsuccessful treatment than smokers (aOR 0.11, 95% CI 0.04–0.32). CONCLUSION CHW-DOT is associated with higher sputum smear conversion rates and a more favourable treatment outcome. The use of tobacco, significantly associated with outcomes, also suggests that a smoking cessation component may be a valuable adjunct to a CHW-DOT approach during TB treatment.
infectious diseases,respiratory system
What problem does this paper attempt to address?